By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann downgraded Sigma-Aldrich to Market Perform from Outperform and reduced its target share price on the firm to a range of between $66 and $70. The bank lowered the EPS estimate for Sigma for full-year 2011 to $3.76 from $3.77. The lower estimates reflect a challenging academic funding environment as well as European macro-environment, an analyst said in a research note.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.